Flagship Biosciences chooses Harte Hanks as marketing solutions partner.

PHILADELPHIA, June 03, 2020 (GLOBE NEWSWIRE) -- Harte Hanks, Inc. (NYSE: HHS), a leading behavioral marketing company, announced today that it has been selected by Flagship Biosciences to provide strategic marketing solutions in developing a new customer acquisition program.
Flagship Biosciences is a leader in technology-driven tissue analysis, and provides expert tissue data insights to pharmaceutical, biotechnology and clinical diagnostic companies.Harte Hanks will be developing a targeted, multi-channel campaign including email, digital advertising and content creation to help Flagship Biosciences engage priority audiences, nurture leads and connect with potential clients.Through extensive behavioral research, Harte Hanks has laid out a strategy for communicating to key decision-makers in Flagshipa??s target biotechnology market. The campaign will convey Flagshipa??s value proposition as a trusted research partner that can accelerate drug development and improve patient outcomes. For the campaign launch, Harte Hanks will provide research, strategic planning, creative messaging and execution.a??Ita??s important that we get our message in front of the critical decision-makers at these pharmaceutical companies and show how we can help improve their clinical results,a?? said Flagship Biosciences CEO Trevor Johnson. a??We chose Harte Hanks for their proven record and expertise in connecting with prospects on a one-to-one level through targeted marketing campaigns.a??
See also:
Leave a comment
  • Latest
  • Read
  • Commented
Calendar Content
«    Июль 2020    »